Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE...
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics LOS ANGELES and AMSTERDAM, April...
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership LOS ANGELES and AMSTERDAM, April...
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That...
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid...
Statement of Renovaro Inc LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in...
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine LOS ANGELES, Feb. 13...
Renovaro Biosciences Announces Results of Special Meeting of Shareholders LOS ANGELES, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Renovaro...
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD Accelerating Healthcare With Award-Winning AI: Big Steps Forward In...
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE...
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Renovaro...
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to...
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine Message from Renovaro Biosciences CEO, The Hon. Mark Dybul...
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine The combined company aims to accelerate precision...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads